Feasibility study for multicenter randomized controlled phase III clinical trial of cisplatin + irinotecan therapy and cisplatin + irinotecan + Krestin [polysaccharide K] therapy for extensive-stage disease (ED) small cell lung cancer

Trial Profile

Feasibility study for multicenter randomized controlled phase III clinical trial of cisplatin + irinotecan therapy and cisplatin + irinotecan + Krestin [polysaccharide K] therapy for extensive-stage disease (ED) small cell lung cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Polysaccharide K (Primary) ; Cisplatin; Irinotecan
  • Indications Small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms RNCLC
  • Most Recent Events

    • 17 Jul 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
    • 30 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top